secwatch.observer — SEC 8-K summary
======================================

Issuer:     GT Biopharma, Inc. (GTBP)
CIK:        0000109657
Form:       8-K
Filed at:   2023-07-05T23:59:59+00:00
Accession:  0001493152-23-023367
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

GT Biopharma annual meeting elects four directors, ratifies auditor
-------------------------------------------------------------------

- Elected directors Michael Breen, Rajesh Shrotriya, Bruce Wendel, and Charles Casamento with majority for votes.
- Ratified Weinberg & Company as independent auditor for 2023: 19,823,634 for, 849,463 against.
- Advisory say-on-pay passed: 8,916,400 for, 2,034,860 against, 13,805 abstain, 9,736,535 broker non-votes.
- Quorum of 55.2% represented at meeting (20,701,600 of 37,493,065 shares outstanding).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/109657/000149315223023367/0001493152-23-023367-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/109657/000149315223023367/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-023367

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer